Analysts Set Axsome Therapeutics, Inc. (NASDAQ:AXSM) PT at $124.64
Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) have earned an average recommendation of “Buy” from the fourteen brokerages that are presently covering the stock, Marketbeat Ratings reports. Fourteen equities research analysts have rated the stock with a buy rating. The average 1 year target price among brokers that have updated their coverage […]
14 Oct 11:01 · The Markets Daily